Celltrion, Top Search Ranking... Stock Price -3.48%
As of 10:30 AM on the 4th, Celltrion is trading at 346,500 KRW, down 3.48% from the previous day. This represents a 14.13% decrease compared to December 7. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Over the past five days, individual investors have net sold 311,135 shares, while foreigners and institutions have net bought 332,749 shares and net sold 5,955 shares, respectively.
On December 29, Celltrion made headlines in the market with the announcement of the "Completion of Global Phase 2 Clinical Trial for COVID-19 Antibody Treatment CT-P59."
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Greater Impact on Women Than Men"... The 'Diet Trap' That Causes Sleepless Nights and Suffering
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※Source: AI Investment Assistant AI Lasso
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
